Allie Kast
Indiana Government Relations Director
Improving Access to Care
Access to Biomarker Testing
ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a person’s own genes or proteins to better diagnose and treat diseases like cancer. Biomarker testing is an important step to accessing precision medicine which includes targeted therapies that can lead to improved survivorship and better quality of life for cancer patients, but insurance coverage for biomarker testing is failing to keep pace with innovations and advancements in treatment.
Support Biomarker Testing for Hoosiers
Biomarker testing is one of the most innovative testing methods for cancer today, helping to ensure patients get the right treatment at the right time. It allows doctors to precisely target the cancer, so some patients may not have to undergo more generalized treatments like chemo and radiation.